Category Archives: Jim’s Corner

Stable Policy Can Help Assure Unwavering Investment in U.S. Biofuels

Jim Greenwood

The Renewable Fuel Standard (RFS) is a unique federal policy that has, just as its bipartisan supporters intended, spurred major domestic and international investment in US biofuels production and it is essential to maintaining a growing market for second generation biofuels. That growing market helps attract investment to advanced biofuel companies who are trying to expand their infrastructure, scale up their production line, and improve their technology foundation. Unfortunately, the Environmental Protection Agency’s (EPA) recent Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Congress Passes Omnibus Spending Agreement

Jim Greenwood

This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill for fiscal 2014, which would, among other things, allow the Food and Drug Administration (FDA) to access $85 million in user fees sequestered in 2013. In addition, BIO supports the agreement’s overall funding for: FDA, NIH, the biodefense enterprise; and improved program oversight of the important 340B program.  BIO also strongly supports the language in the bill providing the Department Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Joins Partners for Healthy Dialogues

Jim Greenwood

The Biotechnology Industry Organization (BIO) recently joined the Partners for Healthy Dialogues effort. Dialogues+ had the opportunity to ask Jim Greenwood, President and CEO of BIO, about why BIO joined the effort, the importance of collaboration and preparing for the Physician Payments Sunshine Act. “BIO and our members support transparency in the life science industry and in the relationships between industry and physicians. We also strongly believe in the value of such relationships for the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO President & CEO Presents Dr. Cohen With Lifetime Achievement Award

Jim-and-Cohen

Last week, Jim Greenwood, President & CEO of the Biotechnology Industry Organization (BIO), attended the 10th Annual BayBio Pantheon Ceremony, where he presented Dr. Stanley N. Cohen with the BayBio Lifetime Achievement DiNA Award for his contributions to making a transformative difference within the life science industry. The event was attended by more than 600 biotechnology innovators, entrepreneurs, investors, elected officials and policy leaders. Dr. Cohen’s groundbreaking work with Dr. Herbert Boyer is widely credited Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

A Manhattan Project for Alzheimer’s Disease

James Greenwood STILL 5_EDIT

Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & CEO Jim Greenwood highlighted the need for our nation to think bigger about how we approach Alzheimer’s Disease. Greenwood called for a “Manhattan Project” to rally the country around addressing this growing health challenge.  He also noted that addressing Alzheimer’s Disease is the type of issue that could bring together elected officials on both sides of the aisle. As part Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , ,